Cargando…

The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer

SIMPLE SUMMARY: Standard treatment for localized renal cell carcinoma (RCC) is surgery. Stereotactic radiotherapy given in a few high dose fractions is a promising treatment for this indication and could be an alternative option for patients unsuitable for surgery. Stereotactic MR-guided radiotherap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tetar, Shyama U., Bohoudi, Omar, Senan, Suresh, Palacios, Miguel A., Oei, Swie S., van der Wel, Antoinet M., Slotman, Berend J., van Moorselaar, R. Jeroen A., Lagerwaard, Frank J., Bruynzeel, Anna M. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601380/ https://www.ncbi.nlm.nih.gov/pubmed/32992844 http://dx.doi.org/10.3390/cancers12102763

Ejemplares similares

Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer
por: Tetar, Shyama U., et al.
Publicado: (2019)

Patient-reported Outcome Measurements on the Tolerance of Magnetic Resonance Imaging-guided Radiation Therapy
por: Tetar, Shyama, et al.
Publicado: (2018)

Magnetic resonance imaging-guided radiotherapy for intermediate- and high-risk prostate cancer: Trade-off between planning target volume margin and online plan adaption
por: Tetar, Shyama U., et al.
Publicado: (2022)

Same-day consultation, simulation and lung Stereotactic Ablative Radiotherapy delivery on a Magnetic Resonance-linac
por: Palacios, Miguel A., et al.
Publicado: (2022)

Combined Inter- and Intrafractional Plan Adaptation Using Fraction Partitioning in Magnetic Resonance-guided Radiotherapy Delivery
por: Lagerwaard, Frank, et al.
Publicado: (2018)

Pitfalls of Ovarian Ablative Magnetic Resonance-guided Radiation Therapy for Refractory Endometriosis
por: Tetar, Shyama, et al.
Publicado: (2018)

Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at risk
por: Schneiders, Famke L., et al.
Publicado: (2023)

Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases
por: van Sörnsen de Koste, John R., et al.
Publicado: (2021)

The clinical introduction of MR-guided radiation therapy from a RTT perspective
por: Botman, R., et al.
Publicado: (2019)

Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy
por: Finazzi, Tobias, et al.
Publicado: (2020)

A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancer
por: Underberg, René WM, et al.
Publicado: (2006)

A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4–10 brain metastases
por: Hartgerink, Dianne, et al.
Publicado: (2021)

Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort
por: Doppenberg, D., et al.
Publicado: (2023)

Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancer
por: Verstegen, Naomi E., et al.
Publicado: (2016)

Verifying 4D gated radiotherapy using time-integrated electronic portal imaging: a phantom and clinical study
por: van Sörnsen de Koste, John R, et al.
Publicado: (2007)

Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study
por: Hurkmans, Coen W, et al.
Publicado: (2009)

A critical review of recent developments in radiotherapy for non-small cell lung cancer
por: Baker, Sarah, et al.
Publicado: (2016)

Online MR-guided radiotherapy – A new era in radiotherapy
por: Slotman, B., et al.
Publicado: (2019)

The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms
por: Dahele, Max, et al.
Publicado: (2011)

Reproducibility of target volumes generated using uncoached 4-dimensional CT scans for peripheral lung cancer
por: van der Geld, Ylanga G, et al.
Publicado: (2006)

Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial
por: Palma, David A, et al.
Publicado: (2012)

Colorectal Pulmonary Metastases: Pulmonary Metastasectomy or Stereotactic Radiotherapy?
por: van Dorp, Martijn, et al.
Publicado: (2023)

Editorial: Online Adaptive MR-Guided Radiotherapy
por: Kerkmeijer, Linda G. W., et al.
Publicado: (2021)

Technical know‐how in stereotactic ablative radiotherapy (SABR)
por: Lo, Simon S., et al.
Publicado: (2016)

The role of biological dose-escalation for pancreatic cancer
por: Bruynzeel, Anna M.E., et al.
Publicado: (2019)

Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy: The Next Step in the Treatment of Renal Cell Carcinoma
por: Keller, Brian, et al.
Publicado: (2021)

1.5T MR-Guided Daily Adaptive Stereotactic Body Radiotherapy for Prostate Re-Irradiation: A Preliminary Report of Toxicity and Clinical Outcomes
por: Cuccia, Francesco, et al.
Publicado: (2022)

Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors
por: Padgett, Kyle R, et al.
Publicado: (2018)

Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results
por: Michalet, Morgan, et al.
Publicado: (2022)

An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastases
por: Ding, Shouliang, et al.
Publicado: (2023)

Clinical outcomes after online adaptive MR-guided stereotactic body radiotherapy for pancreatic tumors on a 1.5 T MR-linac
por: Eijkelenkamp, Hidde, et al.
Publicado: (2023)

Evaluation of a workflow for cone‐beam CT‐guided online adaptive palliative radiotherapy planned using diagnostic CT scans
por: Nelissen, Koen J., et al.
Publicado: (2022)

Effects of two different radiotherapies for craniopharyngiomas using stereotactic radiosurgery/ stereotactic radiotherapy or fractionated stereotactic radiotherapy
por: Kamogawa, Misaki, et al.
Publicado: (2022)

Clinical applicability of and changes in perfusion MR imaging in brain metastases after stereotactic radiotherapy
por: Kerkhof, M., et al.
Publicado: (2018)

Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver Metastases
por: Weykamp, Fabian, et al.
Publicado: (2023)

Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design
por: Doppenberg, D., et al.
Publicado: (2022)

Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer
por: Wujanto, Caryn, et al.
Publicado: (2019)

Dosimetric benefits of daily treatment plan adaptation for prostate cancer stereotactic body radiotherapy
por: Eckl, Miriam, et al.
Publicado: (2021)

Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design
por: Doppenberg, D., et al.
Publicado: (2023)

Whole brain radiotherapy versus stereotactic radiosurgery for 4–10 brain metastases: a phase III randomised multicentre trial
por: Zindler, Jaap D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nq5pa87sbf4pqgfp0biq2vh2jl